Following the news of funding, Roth MKM analyst Scott Fortune has maintained his “Buy” rating on Zyus Life Sciences (Zyus LIfe Sciences Stock Quote, Chart, News, Analysts, Financials TSXV:ZYUS). On September 5, ZYUS completed a private placement of $3.33-million at the price of $0.95. The analyst summarized where ZYUS is at right now. “ZYUS continues […]
A new development has been a drag on its share price, but Ventum Capital Markets analyst Stefan Quenneville is sticking to his guns on Medexus Pharmaceuticals (Medexus Pharmaceuticals Stock Quote, Chart, News, Analysts, Financials TSX:MDP). On September 16, MDP announced that the FDA had extended the review period for the new drug application for treosulfan […]
Share
Tweet
Share
